 CHICAGO--BUSINESS WIRE--Xeris Pharmaceuticals, Inc. Nasdaq: XERS, a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced an exclusive agreement with Tetris Pharma Limited Tetris for the commercialization of Ogluo in the European Economic Area, United Kingdom, and Switzerland the Territory for the treatment of severe hypoglycaemia in adults, adolescents, and chil 